Alerts will be sent to your verified email
Verify Email
SANDUPHQ
|
Sandu Pharmaceutical
|
Roopa Industries
|
Venmax Drugs&Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.72 % | 9.08 % | 1.17 % |
|
5yr average Equity Multiplier
|
1.33 | 4.1 | 0.08 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 1.14 | 0.14 |
|
5yr Avg Net Profit Margin
|
2.27 % | 2.02 % | -19.62 % |
|
Price to Book
|
0.79 | 1.86 | 3.29 |
|
P/E
|
21.16 | 17.63 | 35.24 |
|
5yr Avg Cash Conversion Cycle
|
48.49 Days | 73.02 Days | 288.55 Days |
|
Inventory Days
|
74.6 Days | 122.64 Days | 5.2 Days |
|
Days Receivable
|
26.14 Days | 32.27 Days | 430.69 Days |
|
Days Payable
|
72.73 Days | 105.51 Days | 141.12 Days |
|
5yr Average Interest Coverage Ratio
|
28.2 | 1.96 | -260.56 |
|
5yr Avg ROCE
|
5.33 % | 17.56 % | -47.43 % |
|
5yr Avg Operating Profit Margin
|
3.77 % | 6.21 % | -65.91 % |
|
5 yr average Debt to Equity
|
0.0 | 1.4 | -0.45 |
|
5yr CAGR Net Profit
|
0.39 % | 23.04 % | -42.57 % |
|
5yr Average Return on Assets
|
2.79 % | 2.2 % | 199.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.79 % | 48.03 % | 15.14 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-12.64 % | 0.0 | -7.99 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sandu Pharmaceutical
|
Roopa Industries
|
Venmax Drugs&Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|